این سایت در حال حاضر پشتیبانی نمی شود و امکان دارد داده های نشریات بروز نباشند
Iranian Journal of Medical Sciences، جلد ۵۰، شماره ۱۰، صفحات ۶۹۸-۷۰۶

عنوان فارسی
چکیده فارسی مقاله
کلیدواژه‌های فارسی مقاله

عنوان انگلیسی Prophylactic Intravenous Furosemide for Reducing Hyponatremia Risk in Monopolar Transurethral Prostate Surgery: A Randomized Clinical Trial
چکیده انگلیسی مقاله Background: Transurethral resection of the prostate (TURP) is the gold standard surgical treatment for benign prostatic hyperplasia (BPH). Despite its widespread use, monopolar TURP carries a risk of significant complications, particularly transurethral resection (TUR) syndrome leading to hyponatremia and fluid overload. The study evaluates whether prophylactic furosemide prevents hyponatremia and TUR syndrome in monopolar TURP.
Methods: This study was a triple-blind randomized clinical trial conducted in Al-Zahra and Khorshid educational hospitals of Isfahan, Iran, in 2022-2023. Patients undergoing monopolar TURP, were divided into two groups: those receiving preoperative furosemide and a control group. The primary outcomes were changes in serum sodium levels and the incidence of hyponatremia. Secondary outcomes included fluid balance, complication rates, and recovery times. Continuous data were analyzed using t test/Mann-Whitney U, categorical data with Fisher’s exact test, and time-based changes with repeated measures ANOVA. Normality was checked via Kolmogorov-Smirnov, and power analysis determined sample size.
Results: The furosemide group demonstrated a significantly lower incidence of hyponatremia than the control group (P=0.008). Additionally, serum sodium levels were significantly higher in the furosemide group after surgery (P=0.011), while potassium levels were lower (P=0.003). Mild hypokalemia was observed as a manageable side effect, primarily in patients with baseline potassium levels below 4.1 mmol/L.
Conclusion: Preoperative administration of furosemide effectively reduces the risk of TUR syndrome during monopolar TURP. Furosemide effectively reduces hyponatremia but may increase hypokalemia in some cases, limiting its clinical utility during monopolar TURP. Patient-specific assessment and further research are needed to ensure its safe and effective use.
Trial registration number: IRCT20211208053328N2.
کلیدواژه‌های انگلیسی مقاله Transurethral resection of prostate,Hyponatremia,Furosemide,Water-electrolyte imbalance,Postoperative complications

نویسندگان مقاله Farshad Gholipour |
Department of Urology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

Hossein Bahrami Samani |
Department of Urology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

Alireza Assadi |
School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

Amir Behnamfar |
Department of Urology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

Mohammadjavad Nazarpour |
Department of Urology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

Narjes Saberi |
Department of Urology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran


نشانی اینترنتی https://ijms.sums.ac.ir/article_51161_ed66a584d5722651fe4f8b7e00018653.pdf
فایل مقاله فایلی برای مقاله ذخیره نشده است
کد مقاله (doi)
زبان مقاله منتشر شده en
موضوعات مقاله منتشر شده
نوع مقاله منتشر شده
برگشت به: صفحه اول پایگاه   |   نسخه مرتبط   |   نشریه مرتبط   |   فهرست نشریات